← All organizations

Applied Immunesciences

For profit

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 1

First clinical trial

Last known activity

Nov 2, 1999

Acquired by Rhone-Poulenc Rorer → Aventis → Sanofi-Synthelabo → Sanofi-Aventis on Oct 23, 1995

Timeline

1990s

Jun 1, 1993
Applied Immunesciences— Founded
Oct 23, 1995
Rhone-Poulenc Rorer— Acquired By

2000s

Jan 1, 2004
Sanofi-Aventis— Now

Drugs by trial phase (2 distinct, 1 trials)

Phase 1 (2 own, 0 via acquisition)

Indications

Studied for

HIV Infections

Recent trials (1)

NCT00000680CollaboratorPhase 1Nov 2, 1999

Details

Founded: Santa Clara, CA, US Jun 1, 1993
Last known activity: Nov 2, 1999